According to a research report, medical marijuana sales are forecast to grow to $5.3 billion in 2017, accounting for 67 percent of total cannabis sales.
There has been media attention on drugs known as “K2,” “bath salts,” fentanyl, “molly,” and others, but what's the deal with synthetic marijuana and others?
The cannabis industry is thriving, with growth that translates into more tax revenue for legal states and more money going to small (and large) businesses.